EUVIMEDEUVIMED entdecken
Vergleichsstudie

Assessment of the Phenolics Content in Epilobium angustifolium and Epilobium hirsutum Extracts and Their Pharmacological Activity

Kateryna Uminska, Michal Korinek iD, Liudas Ivanauskas iD, Mohamed El-Shazly iD, Victoriya Georgiyants iD, Yu-Li Chen iD, Monu Kumar Shukla iD, Sedin Renadi iD, Tsong-Long Hwang iD, Fang-Rong Chang iD, Olha Mykhailenko iD

Archiv der Pharmazie · 2025-05 · 358 (5)

DOI: 10.1002/ardp.202400765 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Archiv der Pharmazie, online erschienen am 13.05.2025. Verfasst von Kateryna Uminska und 10 weiteren Autor:innen. Beteiligte Einrichtung: Zhytomyr Basic Pharmaceutical Professional College, Zhytomyr, Ukraine. Hauptthemen laut MEDLINE: Epilobium, Plant Extracts, SARS-CoV-2, Phenols. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: This study was supported by grants from the National Science and Technology Council (NSTC), Taiwan (NSTC 113-2320-B-037-023, 112-2320-B-037-012, and 111-2320-B….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The recent outbreak of Omicron strains of coronavirus disease urged the search for novel treatments from natural products such as Epilobium species. The present work reports a comparative HPLC‐DAD study of the polyphenolic composition of the crude extracts of Epilobium angustifolium and Epilobium hirsutum . Oenothein B, gallic acid, hyperoside, and isoquercitin were the dominant phenolic compounds. E. hirsutum methanol extract showed a high radical scavenging activity as demonstrated by the HPLC‐ABTS assay due to its richness in phenolic compounds. The polysaccharide‐rich extracts and water extracts of E. hirsutum showed potent anti‐coronavirus SARS‐CoV‐2 activity against the Omicron strain at 10 μg/mL with inhibition percentages of 38.4% and 46.1%, respectively. In contrast, the methanol (50% v/v) extract was inactive. Rutin and chlorogenic acid docked well into the binding pocket of the coronavirus spike protein. Emerging evidence suggests that suppressing excessive neutrophilic inflammation during the late stage of coronavirus infection benefits patients’ survival. The methanol extracts of both plants completely inhibited fMLF/CB‐induced elastase release in human neutrophils at 10 μg/mL (IC 50 2.44 μg/mL), while the water extract showed an IC 50 of 5.67 μg/mL. While several compounds docked well into the spike protein, the major and marker compound oenothein B showed promising in vitro anti‐coronavirus activity with an IC 50 of 6.08 µM in hACE2‐overexpressing HEK293 cells, mimicking the entry of wild‐type SARS‐CoV‐2 into human host cells. The results indicated that E. hirsutum might be helpful in the treatment of coronavirus infections and related inflammatory syndromes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilobiumPlant ExtractsSARS-CoV-2PhenolsAntiviral AgentsCOVID-19 Drug TreatmentHumansCOVID-19Chromatography, High Pressure LiquidSpike Glycoprotein, CoronavirusMolecular Docking Simulation

Stichwörter der Autor:innen

Epilobium angustifoliumEpilobium hirsutumOmicronneutrophilic inflammationpolyphenolics

Substanzen

Plant ExtractsPhenolsAntiviral AgentsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Zhytomyr Basic Pharmaceutical Professional College, Zhytomyr, Ukraine.
  • Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Graduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Department of Analytical and Toxicological Chemistry, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.

ORCID-Profile: Michal Korinek, Liudas Ivanauskas, Mohamed El-Shazly, Victoriya Georgiyants, Yu-Li Chen, Monu Kumar Shukla, Sedin Renadi, Tsong-Long Hwang, Fang-Rong Chang, Olha Mykhailenko

Förderung

  • This study was supported by grants from the National Science and Technology Council (NSTC), Taiwan (NSTC 113-2320-B-037-023, 112-2320-B-037-012, and 111-2320-B…

Zitieren

APA

Uminska, K., Korinek, M., Ivanauskas, L., El-Shazly, M., Georgiyants, V., Chen, Y. L., Shukla, M. K., Renadi, S., Hwang, T. L., Chang, F. R., & Mykhailenko, O. (2025). Assessment of the Phenolics Content in Epilobium angustifolium and Epilobium hirsutum Extracts and Their Pharmacological Activity. Archiv der Pharmazie, 358(5). https://doi.org/10.1002/ardp.202400765

Vancouver

Uminska K, Korinek M, Ivanauskas L, El-Shazly M, Georgiyants V, Chen YL, et al. Assessment of the Phenolics Content in Epilobium angustifolium and Epilobium hirsutum Extracts and Their Pharmacological Activity. Archiv der Pharmazie. 2025;358(5). doi:10.1002/ardp.202400765

BibTeX
@article{Uminska2025,
  author = {Uminska, Kateryna and Korinek, Michal and Ivanauskas, Liudas and El-Shazly, Mohamed and Georgiyants, Victoriya and Chen, Yu-Li and Shukla, Monu Kumar and Renadi, Sedin and Hwang, Tsong-Long and Chang, Fang-Rong and Mykhailenko, Olha},
  title = {Assessment of the Phenolics Content in Epilobium angustifolium and Epilobium hirsutum Extracts and Their Pharmacological Activity},
  journal = {Archiv der Pharmazie},
  year = {2025},
  volume = {358},
  number = {5},
  doi = {10.1002/ardp.202400765}
}
Kostenlos starten →